<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>JAK Inhibition and the Future of HS Treatment</title>
  <description>The management of hidradenitis suppurativa (HS) is evolving, but many patients still face significant hurdles in achieving optimal outcomes with current therapies. In this episode, &amp;quot;JAK Inhibition and the Future of HS Treatment,&amp;quot; expert dermatologists, Hadar Lev-Tov, MD, and Jennifer L. Hsiao, MD discuss:   Increasing Awareness: Debunking common myths and misconceptions about HS.   Building Trust: Strategies for overcoming diagnostic delays and insufficient management.   Comprehensive Care: Adopting a holistic approach, including addressing common comorbidities.   The Road Ahead: Exploring the future of the HS treatment landscape, including JAK inhibition.   </description>
  <author_name>DermDocs</author_name>
  <author_url>http://dermdocs.libsyn.com/website</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/39293520/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/196243955</thumbnail_url>
</oembed>
